tiprankstipranks
Advertisement
Advertisement
PMV Pharmaceuticals reports Q2 EPS (34c), consensus (40c)
PremiumThe FlyPMV Pharmaceuticals reports Q2 EPS (34c), consensus (40c)
22d ago
PMV Pharmaceuticals assumed with a Buy at Ladenburg
Premium
The Fly
PMV Pharmaceuticals assumed with a Buy at Ladenburg
2M ago
PMV Pharmaceuticals Shareholders Back Directors and Governance Matters
Premium
Company Announcements
PMV Pharmaceuticals Shareholders Back Directors and Governance Matters
3M ago
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
PremiumThe FlyPMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
5M ago
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
Premium
Company Announcements
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
6M ago
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
Premium
The Fly
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
6M ago
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
PremiumRatingsPromising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
10M ago
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
Premium
Ratings
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
10M ago
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
Premium
The Fly
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100